Delivery Order SPE2DR25D2005-SPE2DR26FE6W0
- Not listed
- The Defense Logistics Agency awarded a $33,081.12 delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) with an ultimate completion date of August 14, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a child contract under AmerisourceBergen's larger federal contract vehicle. The pharmaceutical products will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $5,864.87 to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count supply) on September 24, 2025, with completion targeted for September 25, 2025. This competitively awarded, firm fixed-price delivery order represents a pediatric/oncology pharmaceutical supply within the federal medical procurement system. The contract was fulfilled by AmerisourceBergen's Corporate Office division, with performance conducted at...
- The Defense Logistics Agency awarded a $8,321.43 delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) with a completion date of June 26, 2025. This competitive award employs a firm fixed price structure with no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving federal...
- The Defense Logistics Agency awarded a delivery order valued at $2,528.49 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets in a 30-count package. The contract is a firm fixed price delivery order with an ultimate completion date of November 10, 2025, and was competitively awarded with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a $1,293.48 firm fixed price delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count) with a completion date of September 19, 2025. This competitively awarded, non-set-aside contract represents a single delivery order against AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $4,445.95 delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT (orally disintegrating tablet) 4 mg tablets in quantities of 30, with an ultimate completion date of June 20, 2025. This competitively awarded, firm fixed-price contract reflects a non-set-aside procurement and represents a continuation of AmerisourceBergen's ongoing pharmaceutical supply relationship with DLA. The contract specifies performance at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $18,470.50 to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count packaging). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 28, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine...
- The Defense Logistics Agency awarded a delivery order valued at $2,181.96 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count packages). This competitive, non-set-aside contract carries a firm fixed price structure with an ultimate completion date of August 6, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. The delivery order represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $3,168.39 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count packages). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, with performance to be completed by July 18, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order valued at $20,798.10 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. The contract is a firm fixed price delivery order with no set-aside designation, competitively awarded on September 9, 2025, with an ultimate completion date of September 10, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this transaction. This delivery...
- SPE2DR25D2005Indefinite Delivery Contract
- SPE2DR25D2005-SPE2DR26FE6W0Delivery Order
The Defense Logistics Agency awarded a $41,606.24 delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) with an ultimate completion date of November 17, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement for pharmaceutical products supporting federal medical supply needs. The product will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion and extending through December 2026. This prime vehicle serves as a comprehensive global pharmaceutical support contract enabling AmerisourceBergen to supply a broad range of pharmaceutical products, medical supplies, vaccines, and specialty medications to support military healthcare programs and other federal customers including the Defense Health Agency and U.S. Coast Guard. The company's demonstrated capability in federal pharmaceutical procurement and competitive positioning reflects its role as a major healthcare solutions provider within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $41.6k | 11/14/25 |